New Medication Discovery - VU0409551/JNJ-46778212: An mGlu5 Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia

Summary:

On the basis of its robust in vitro potency and in vivo efficacy in multiple preclinical models of multiple domains of schizophrenia, coupled with a good DMPK profile and an acceptable therapeutic window, the new drug was selected as a candidate for further development.

4 Likes

New research focused on this compound (VU0409551):

1 Like

Interesting. I hope it does well. It will take five years to come to market won’t it? Until then I’m more excited about the once coming out sooner.

It takes allot longer then 5 years from discovery to come out, more like 13 years.

1 Like

Wow. What’s that mean for Iti-007

nothing that drug was discovered along time ago, its in phase 3